ハイコンテントスクリーニング (HCS) / イメージング：技術と世界市場
High Content Screening/Imaging: Technologies and Global Markets
|出版日||ページ情報||英文 171 Pages
|ハイコンテントスクリーニング (HCS) / イメージング：技術と世界市場 High Content Screening/Imaging: Technologies and Global Markets|
|出版日: 2018年10月23日||ページ情報: 英文 171 Pages||
世界のハイコンテントスクリーニング (HCS) / イメージング市場は、2018年の9億1,500万米ドルから2023年までに17億米ドルへ達すると予測され、この間は13.1%のCAGR (年間複合成長率) が見込まれています。
当レポートでは、世界のハイコンテントスクリーニング (HCS) / イメージング市場について調査し、市場および技術の概要、市場動向とデータ実績・予測、技術進歩の詳細分析、および主要企業のプロファイルなどを提供しています。
The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.
Instrument or platform as a segment of high content screening/imaging should grow from $630.0 million in 2018 to reach $1.1 billion by 2023 at a CAGR of 12.2% for the period of 2018-2023.
Software and analytics as a segment of high content screening/imaging should grow from $70.0 million in 2018 to reach $151.0 million by 2023 at a CAGR of 16.6% for the period of 2018-2023.
The HCS/I market has significant potential due to rising demand from the drug discovery and molecular diagnosis segments. The capabilities and possibilities of HCS/I market growth increases with the growth of new technologies and technological advancements. Emerging economies such as China, India, and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the market. Investments and funding from government and private ventures, research institutes and universities are supporting exploration into the potential of this market. Growing drug discovery and molecular diagnostic and research through HCS/I will further boost the market in the near future. The global rise in infectious and noninfectious diseases, growing populations, technological advancements and innovation are other factors creating considerable demand for HCS/I.
The scope of this study encompasses the current market for drug discovery, molecular diagnostics, cancer research, personalized medicine and compound profiling. The report also includes regulatory aspects, recent developments, market projections, competitive landscapes and market share. Analyses of patents, clinical trials, innovations and opportunities, as well as the latest trends, are also discussed in the report. The report intends to explain the key trends of HCS/I technologies and applications in various geographies. It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.